Bio-Rad Laboratories (BIO-B) Inventory Average (2010 - 2026)

Bio-Rad Laboratories (BIO-B) has 17 years of Inventory Average data on file, last reported at $755.6 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $755.6 million, down 2.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $755.6 million (down 2.51% YoY), and the FY2025 annual result was $750.4 million, down 2.58% from the prior year.
• Inventory Average declined to $755.6 million in Q1 2026 per BIO-B's latest filing, from $761.9 million in the prior quarter.
• Over five years, Inventory Average peaked at $804.0 million in Q3 2024 and troughed at $588.9 million in Q1 2022.
• A 5-year average of $746.4 million and a median of $775.0 million in 2025 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2023: Inventory Average fell 4.05% in 2022, then advanced 25.01% in 2023.
• A 5-year view of Inventory Average shows it stood at $702.6 million in 2022, then advanced by 10.75% to $778.2 million in 2023, then increased by 0.51% to $782.1 million in 2024, then dropped by 2.58% to $761.9 million in 2025, then dropped by 0.83% to $755.6 million in 2026.
• Business Quant data shows BIO-B's Inventory Average at $755.6 million in Q1 2026, $761.9 million in Q4 2025, and $791.0 million in Q3 2025.